Diagnosis

148 trials 73 recruiting

Filter these 148 trials by phase, country and sponsor.

Open in Search →

In vivo biological standardization of Dermatophagoides allergen extracts. Not authorised

2024-514108-15-00 Allergies 4
Role of contrast enhanced mammography with Iomeprol 400 mgI/ml (Iomeron, Bracco), in the identification of breast cancer: I3-MaC Study Not authorised

2024-513251-32-00 Breast cancer 6
A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po… Not authorised

2025-521052-35-00 Patients with HER2Positive Advanced Breast Cancer 7
[68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic canc… Not authorised

2023-503632-41-00 Pancreatic cancer and gastroesophageal cancer (esophagu 4
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with… Not authorised

2023-503686-26-00 Progressive Pulmonary Fibrosis (PPF) 9
18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study Not authorised

2023-508066-15-00 Hormone-positive breast cancer 4
Early detection of triple negative breast cancer relapse (CUPCAKE) Not authorised

2022-501562-22-00 Triple-negative breast cancer (TNBC) patients at high r 4
Safety, Tolerability, and Imaging Quality of HarMono-T Contrast Agent During Ultrasound of the Kidney in Healthy Subjects Not authorised

2024-514924-17-00 Ultrasound contrast agent, for diagnostic purposes (to 9
A multicentre, prospective, open-label study with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predi… Pending

2024-512721-89-00 Breast Cancer 4
64CuCl2 PET/CT VS 18F-choline PET/CT in prostate cancer Pending

2025-520861-29-00 Prostate cancer at risk of developing metastatic lesion 5
Use of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to … Pending

2025-520868-17-00 Cancer on the prostatic bed 5
uPAR PET/MRI in glioma Pending

2024-519723-20-01 Glioma 9
Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischemic heart disease Pending

2024-518640-20-00 Chronic ischemic heart disease 4
Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY) Pending

2024-519737-30-00 Roux-en-Y gastric bypass 6
Long-term impact of GBCAs on motor and cognitive function following repeated Contrast-Enhanced MRI—ODYSSEY Pending

2024-515462-14-00 Long term potential effect of repeated exposure to eith 6
VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION - ENDOTHELIN-2 Pending

2024-515928-36-00 Uncontrolled arterial hypertension 4
PREDONATION RENAL RESERVE: IMPACT ON THE EVOLUTION OF DONOR AND RECIPIENT RENAL FUNCTION IN A LIVING DONOR RENAL TRANSPLANTATION PROGRAMME Pending

2024-519757-11-00 Renal Transplantation, living donor 5
Pre- and post-treatment evaluation of lung function with Xenon-gas enhanced Dual-Energy CT-imaging in patients undergoing radiotherapy Pending

2025-521559-22-00 Radiation-induced lung injury (radiation fibrosis, radi 10
Staging of gastric cancers by PET-FAPI Pending

2025-524434-25-00 gastric cancer 4
Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Cardiovascular disease 5
COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study Pending

2024-512350-17-01 Patients with coronary artery disease and an indication 6
New PET/CT for (possible) cardiac sarcoidosis Pending

2025-523646-27-00 Cardiac Sarcoidosis 4
Measuring of the duration of action of different doses of rocuronium-induced neuromuscular block in infants during surgical treatment of cra… Pending

2024-515545-41-00 a prospective, case-controlled study 6
Clinical Application of the Androgen Receptor Inhibitor Darolutamide to Upregulate the Prostate-Specific Membrane Antigen (PSMA) Protein Exp… Pending

2025-520482-52-03 Prostate cancer 9